Understanding the role of transmembrane proteins for Plasmodium cell division
Project Number1F32AI186297-01
Contact PI/Project LeaderBACK, PETER S
Awardee OrganizationBOSTON CHILDREN'S HOSPITAL
Description
Abstract Text
Project Summary
Plasmodium falciparum is a unicellular eukaryote that causes the most severe form of human malaria. In
the human blood stage of malaria infection, P. falciparum undergoes asexual replication to propagate itself
exponentially, resulting in the classic symptoms of malaria. This is a critical stage of the parasite’s life cycle and
a compelling process to target for new therapeutics. Plasmodium utilizes a divergent form of cell division with a
unique method of cytokinesis called segmentation, wherein genetic material and organelles are simultaneously
partitioned into 20-36 daughter cells. This is a high-fidelity process that is largely driven by the basal complex,
the putative contractile ring of the parasite. Despite its pivotal role for parasite survival and proliferation, our
mechanistic understanding of the basal complex is limited. To address this knowledge gap, our lab and others
have identified a dozen proteins that comprise the basal complex. Of these, three proteins emerged as a
subgroup, each of which contain transmembrane domains. Previous studies demonstrate that they localize to
the basal complex and my preliminary data suggests that at least one of these is important for parasite
replication. It remains unclear, however, whether these proteins are associated with a membrane and what
specific function they serve during segmentation. In this study, I will integrate biochemical and super-resolution
microscopy approaches to decipher the precise location of the transmembrane proteins. This will provide direct
evidence of a link between the basal complex and parasite membrane. I will also use direct and inducible
knockout systems together with cell viability assays and live-cell microscopy to thoroughly interrogate the
function of the transmembrane proteins. This will reveal how transmembrane domains contribute to the broader
cytokinetic function of the basal complex. Collectively, the findings from this study will represent the first step
towards a mechanistic understanding of the basal complex in Plasmodium. Further, insights from this study will
enable future comparative analyses between parasites and model eukaryotes, revealing parasite-specific
adaptations that can be leveraged for novel therapeutics.
The proposed research will thoroughly develop my conceptual and technical expertise in Plasmodium
biology. Specifically, this proposal will expand my current skills in biochemical, microscopy, and genetic
techniques, honing my technical expertise and establishing a research niche. Moreover, I aim to leverage both
our understanding of eukaryotic cell division and my experience in the related parasite Toxoplasma, to achieve
these goals. Training at Boston Children’s Hospital and within the larger Harvard community offers a rich and
stimulating environment to support this proposal and my development as a scientist and mentor. Here, I will build
strong scientific relationships with leaders in microbiology and molecular biology through local meetings and
international conferences and commit to training the next generation of scientists. Overall, I am well positioned
to carry out this research and propel my career towards an independent investigator position.
Public Health Relevance Statement
PROJECT NARRATIVE
The malaria parasite causes a staggering global health burden, yet its key biological structures and processes
remain understudied. To better understand parasite cell division, this proposal focuses on the proteins that
comprise the cytokinesis-driving contractile ring. By investigating the role of three transmembrane proteins, the
goal is to reveal novel insights into parasite-specific mechanisms of cytokinesis that can inform the next
generation of antimalarial drugs.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
076593722
UEI
Z1L9F1MM1RY3
Project Start Date
01-November-2024
Project End Date
31-October-2027
Budget Start Date
01-November-2024
Budget End Date
31-October-2025
Project Funding Information for 2024
Total Funding
$73,828
Direct Costs
$73,828
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$73,828
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F32AI186297-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32AI186297-01
Patents
No Patents information available for 1F32AI186297-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32AI186297-01
Clinical Studies
No Clinical Studies information available for 1F32AI186297-01
News and More
Related News Releases
No news release information available for 1F32AI186297-01
History
No Historical information available for 1F32AI186297-01
Similar Projects
No Similar Projects information available for 1F32AI186297-01